Earnings History Data for Assembly Biosciences (ASMB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Assembly Biosciences

Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for the treatment of fecal incontinence. The Company is also developing novel microbiome-based technology for targeted oral delivery of therapeutic bacteria, complex proteins, viral antigens and small molecules to treat intractable infectious diseases of the GI tract, such as C. difficile infections. Assembly Biosciences Inc., formerly known as Ventrus Biosciences, Inc., is based in New York.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		ASMB	Assembly Biosciences	105.00	-1.51	-2.02	0.00	Assembly Biosciences GAAP EPS of -$1.51, revenue of $6.85M [11/8/2024 12:14 AM]	16.46	-1.04 (-5.94%)	17.50	0.0 (0.00%)	7.69 - 19.93	29,240	20,000	578
Assembly Biosciences GAAP EPS of -$1.51, revenue of $6.85M [11/8/2024 12:14 AM]
08-08-2024	AH		ASMB	Assembly Biosciences	74.00	-1.98	-2.96	0.00	Assembly Biosciences GAAP EPS of -$1.98 beats by $0.25 [8/8/2024 6:29 PM]	13.00	-0.38 (-2.84%)	0.0	0.0 (0.00%)	7.69 - 20.04	9,162	10,000	0
Assembly Biosciences GAAP EPS of -$1.98 beats by $0.25 [8/8/2024 6:29 PM]
08-11-2023	AH		ASMB	Assembly Biosciences	46.00	-0.27	-0.23	0.00	Assembly Biosciences GAAP EPS of -$0.27 misses by $0.04 [11/8/2023 5:18 PM]	0.7475	-0.10 (-12.22%)	0.86	0.01 (1.00%)	0.67 - 1.78	1,767,461	710,000	7,946
Assembly Biosciences GAAP EPS of -$0.27 misses by $0.04 [11/8/2023 5:18 PM] Assembly Biosciences names Gaggar as its chief medical officer [11/8/2023 8:30 AM]
22-03-2023	AH		ASMB	Assembly Biosciences	60.00	-0.46	-0.56	0.00	Assembly Biosciences GAAP EPS of -$1.92 in-line [3/22/2023 4:58 PM]	1.07	-0.10 (-8.54%)	1.18	0.01 (0.85%)	0.82 - 2.42	578,500	210,000	2,109
Assembly Biosciences GAAP EPS of -$1.92 in-line [3/22/2023 4:58 PM]
08-11-2022	AH	4:05 PM ET (Nov 8)	ASMB	Assembly Biosciences	74.00	-0.48	-0.47	0.00	Assembly Biosciences GAAP EPS of -$0.48 beats by $0.06 [11/8/2022 5:04 PM]	1.30	-0.07 (-5.11%)	1.34	-0.03 (-2.19%)	1.20 - 3.15	414,227	230,000	6,908
Assembly Biosciences GAAP EPS of -$0.48 beats by $0.06 [11/8/2022 5:04 PM]
09-08-2022	AH	4:05 PM ET (Aug 9)	ASMB	Assembly Biosciences	104.00	-0.51	-0.49	0.00	Assembly Biosciences GAAP EPS of -$0.51 [8/9/2022 5:22 PM]	2.17	0.01 (0.46%)	2.15	-0.01 (-0.46%)	1.32 - 3.94	284,251	300,000	500
Assembly Biosciences GAAP EPS of -$0.51 [8/9/2022 5:22 PM] Assembly Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlights [Aug-09-22 04:05PM]
05-08-2021	AH	4:05 PM ET (Aug 5)	ASMB	Assembly Biosciences, Inc.	139.35	-0.55	-0.64	0.19	Assembly Biosciences EPS beats by $0.11 [8/5/2021 5:07 PM]	3.66	0.02 (0.41%)	3.70	0.05 (1.37%)	3.32 - 23.39	863,376	880,000	5,184
Assembly Bio Announces Key Promotions to Leadership Team [Aug-03-21 08:00AM] Assembly Biosciences (ASMB) Reports Q2 Loss, Lags Revenue Estimates [Aug-05-21 05:45PM] Assembly Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights [Aug-05-21 04:01PM]
06-05-2021	AH	4:05 PM ET (May 6)	ASMB	Assembly Biosciences, Inc.	162.64	-0.69	-0.79	-0.76	Assembly Biosciences EPS beats by $0.10 [5/6/2021 5:07 PM]	4.05	0.13 (3.32%)	3.96	0.04 (1.02%)	3.84 - 27.84	584,179	930,000	3,432
Assembly Biosciences EPS beats by $0.10 [5/6/2021 5:07 PM] Assembly Biosciences Reports First Quarter 2021 Financial Results and Recent Updates [May-06-21 04:05PM] Assembly Biosciences (ASMB) Reports Q1 Loss, Lags Revenue Estimates [May-06-21 08:35PM] Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [May-07-21 05:00PM]
05-11-2020	AH		ASMB	Assembly Biosciences, Inc.	488.88	-0.09	-0.78	-0.96	Assembly Biosciences EPS beats by $0.69, beats on revenue [11/5/2020 4:58 PM]	4.82	-11.08 (-69.69%)	6.25	-9.65 (-60.69%)	4.78 - 27.84	19,572,878	320,856	1,384,207